Disengagement of the surface BcR caused by treatment is likely to reinstate the pre-stimulation conditions of CLL cells and is particularly evident at the level of surface IgM, the most frequently engaged isotype [187]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.